1-[1-[4-(4-Fluorophenyl)-4-Oxobutyl]Piperidin-4-Yl]-3-Methylbenzimidazol-2-One

CAS: 133066-70-3

Ref. 3D-FF100333

Produktinformation

• Name: 1-[1-[4-(4-Fluorophenyl)-4-Oxobutyl]Piperidin-4-Yl]-3-Methylbenzimidazol-2-One
• Synonyme: 1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-4-piperidinyl)-1,3-dihydro-3-(methyl-11C)-2H-benzimidazol-2-one, N-(11C)Methyl-benperidol, 2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl)-1,3-dihydro-3-(methyl-11C)-, 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl}-3-methyl-1,3-dihydro-2H-benzimidazol-2-one

Beschreibung

1-[1-[4-(4-Fluorophenyl)-4-Oxobutyl]Piperidin-4-Yl]-3-Methylbenzimidazol-2-One is a novel dopamine agonist that has been shown to be an alerting agent with potential therapeutic use in the treatment of ADHD and other sleep disorders. Studies have also shown that it has a stimulatory effect on dopamine receptors, which are located in the striatum. 1-[1-[4-(4-Fluorophenyl)-4-Oxobutyl]Piperidin-4-Yl]-3-Methylbenzimidazol-2-One binds to both D2 and D3 dopamine receptors with high affinity and selectivity. It has been shown that 1-[1-[4-(4-Fluorophenyl)-4-Oxobutyl]Piperidin-4-Yl]-3-Methyl

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 395.47 g/mol
• Formel: C₂₃H₂₆FN₃O₂
• Reinheit: Min. 95%
• InChl: InChI=1S/C23H26FN3O2/c1-25-20-5-2-3-6-21(20)27(23(25)29)19-12-15-26(16-13-19)14-4-7-22(28)17-8-10-18(24)11-9-17/h2-3,5-6,8-11,19H,4,7,12-16H2,1H3
• InChI Key: InChIKey=SJRJDHOLKUXKIB-UHFFFAOYSA-N
• SMILES: Cn1c(=O)n(C2CCN(CCCC(=O)c3ccc(F)cc3)CC2)c2ccccc21